A Clinical Trial of Transcatheter Aortic Valves in Dialysis Patients (Japan)
← catalyst calendarSponsored by Edwards Lifesciences (industry) · EW — their whole pipeline →.
Phase
Not applicable
Status
Active, not recruiting
Study type
Interventional
Design
Na · None · Treatment
Enrollment
38actual
Sites
2
Country
Japan
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | Sep 2016 | actual | When the study began enrolling |
| Primary completion | 2019-02-14 | actual | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | Jan 2026 | estimated | The whole study's end, after follow-up |
| First posted | 2016-09-16 | estimated | When this record first appeared on the registry |
| Results posted | 2020-09-24 | actual | When the sponsor posted results to the registry |
| Record updated | 2024-09-25 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Aortic Stenosis
Intervention
- Device: Transcatheter Aortic Valve Implantation (TAVI)
Primary outcome
what the primary-completion date above is the date OFMortality
measured 1 year
Posted documents
hosted by the registry — we link, never re-serveStudy Protocol and Statistical Analysis Planposted 2020-01-06 · 1.7 MB · Prot_SAP_000.pdf
Permalink · EW's whole pipeline · Catalyst calendar · Every registered study · What changed